Skip to main content
. 2020 Aug 4;11(4):e01183-20. doi: 10.1128/mBio.01183-20

FIG 10.

FIG 10

sCAMs are increased in the plasma samples from ZIKV+ patients. (a) ZIKV-infected patients from the CARBO cohorts. (b) CXCL10 levels in healthy blood donors and ZIKV+ patients were measured by ELISAs. Results are expressed as means ± SEMs (24 healthy, 24 ZIKV+ plasma samples [12 neuro and 12 non-neuro]) and analyzed using a Wilcoxon-Mann-Whitney test. ****, P < 0.0001 compared to healthy plasma. (c and d) Soluble ICAM-1 and VCAM-1 levels in healthy blood donors and ZIKV+ patients were measured by ELISAs. Results are expressed means ± SEMs (24 healthy, 24 ZIKV+ plasma samples [12 neuro and 12 non-neuro]) and analyzed using a Wilcoxon-Mann-Whitney test. *, P < 0.05; **, P < 0.01; ****, P < 0.0001 compared to healthy plasma samples.